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Tetraparesis is more often a clinical feature of
profound hypokalaemia 1,2 than hyperkalaemia.
Neurological featuresofhyperkalaemiaarerarely
seen in clinical practice, as they are precludedby
cardiotoxic complications such as arrhythmias.
However, patients may develop flaccidparalysis
of skeletal muscle with areflexia mimicking
symptoms ofacute inflammatory demyelinating
polyneuropathy.3 Severehyperkalaemicparalysis
has previously been reported secondary to
nonsteroidal anti-inflammatory drugs 4
spironolactone,5 and a combination of chronic
renal failure and ACE inhibitors.6 We report a
case ofpost-operative secondary hyperkalaemic
paralysispresentingwithneurological symptoms
18 daysafterananteriorresection(withdiverting
loop ileostomy) for a rectosigmoid colonic
adenocarcinoma.
CASEREPORT A57-year-oldmanwasreferred
to the colorectal clinic with symptoms ofchange
in bowel habit, colicky central abdominal pain
and weight loss. He had a history of maturity
onset diabetes mellitus, hypertension and
peripheral vascular disease having previously
had a right femoral angioplasty. Medication
consisted of metformin, gliclazide, amlodipine,
atorvastatin, aspirinandlisinoprilcombinedwith
a thiazide diuretic. A double contrast barium
enema and flexible sigmoidoscopy revealed a
polypoid lesion at the rectosigmoid junction.
Histology of representative biopsies confirmed
endoscopic suspicion of an adenocarcinoma. He
underwentatechnicallydifficultanteriorresection
withformationofadefunctioningloopileostomy.
Histopathology reported a Dukes' Cl (PT3 NI
Mx) rectal adenocarcinoma, which extended to
within 1mmofthe circumferential margin. Apart
from poor post-operative glycaemic control
necessitating an increased dose ofmetformin, he
made a relatively uneventful recovery and was
discharged home on the twelfth post-operative
day, confident with ileostomy management. The
electrolytes werenormal atthetimeofdischarge.
After48 hours hedevelopedincreased ileostomy
effluentoutputfollowedbysymptomsofanorexia,
nausea then vomiting. By the following day he
was feeling generally tired and weak. He
continued to deteriorate over the next 48 hours,
and became bedbound. There were however no
bulbar or respiratory symptoms.
On readmission clinical examination revealed
thathewas afebrilebutmarkedlydehydratedand
weak, hypotensive (75/50 mmHg) with a heart
rate of 60 beats/min and respiratory rate of
14 breaths/min. Capillary blood glucose was
18 mmol/L. Abdominal and respiratory
examination were unremarkable. Glasgow coma
scale was 15/15, there was no facial asymmetry
and other cranial nerves were unaffected.
Neurological examination of the limbs revealed
profound weakness ofallfourlimbs, particularly
distally (MRC grade 1-2/5). Hewas areflexic and
generally flaccid. There was no sensory deficit
and plantar responses were bilaterally flexor.
The differential diagnosis was wide (Table).
Blood results at the time ofadmission revealed a
serum potassium of 8.8mmol/L (confirmed on
repeat sample), urea 45.8mmol/L, creatinine
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TABLE
Differential diagnosis
Acuteinflammatorydemyelinatingpolyneuropathy(AIDP)
Metabolic neuropathy/myopathy
Carcinomatous neuropathy/myopathy
Lambert-Eaton myasthenic asyndrome
Critical illness neuropathy/myopathy
644umol/Landacompensatedmetabolicacidosis
(baseexcess-9.5). Anelectrocardiogram showed
T wave 'tenting' consistent with hyperkalaemia.
Calcium gluconate was administered
intravenously with oral calcium resonium
subsequently. Twoconsecutiveinfusions of50%
dextrose and insulin were administered with
normal saline rehydration resulting in resolution
of the acidosis and improvement in the
electrolytes. Within hours of treatment
neurological symptoms resolved and muscle
powerreturned.Ureaandcreatininefelltonormal
levelsovercourseofoneweek. Hewasdischarged
9 days after readmission and has remained well.
DISCUSSION
Hyperkalaemic paralysis can be primary or
secondary. Patients with primary episodic or
hereditaryhyperkalaemicperiodicparalysishave
a genetically determined defect in the sodium
channels of muscle fibre membranes
(channelopathy).7 Typically the clinical onset is
in the first decade of life with attacks of flaccid
paralysis lasting from a few minutes to several
hours, at intervals of hours to days. Attacks are
usually induced by the ingestion of potassium
and by rest after exercise. Affected individuals
mayexhibittheability to"walkoff' anattackand
can be successfully treated by thiazide diuretics,
acetazolamide and salbutamol.
Secondary hyperkalaemic paralysis occurs later
in life and is caused by a partial defect in the
sodium channels of muscle fibre membranes,
howevertheprecisemechanismisunknown. The
potassium may have either a direct effect on the
muscle cell membrane or possibly disturb the
peripheralnervessupplyingthemuscle.7Itusually
occursinelderlypatientswithunderlyingchronic
renal impairment, but can be precipitated by
drugs4'5'6 or trauma.8 Flaccid paralysis with
areflexia (initially affecting the legs and
progressing to the arms) with preservation of
sensation and cranial nerve function are signs
common to both hyperkalaemic paralysis and
acute inflammatory demyelinating poly-
neuropathy(Guillain-Barresyndrome). Paralysis
can be so severe and progressive as to involve
respiratory muscles necessitating artificial
ventilation.9 This also has implications for the
anaesthetist's choice of muscle relaxant prior to
intubation. A depolarising agent such as
suxamethonium may further increase serum
potassium precipitating a fatal arrhythmia.
The largest cohort of cases of secondary
hyperkalaemicparalysisintheliteraturesuggests
that the clinical presentation and subsequent
clinical course in our patient is typical of this
condition. Ofthe 18 cases described by Evers et
al,15 presented with tetraparesis/tetraplegia and
three with paraparesis. Paralysis typically began
distally with an ascending course and although
significantsensory signswerenotfound, sensory
symptoms were reported in five cases. The mean
serum potassium concentration at presentation
was 9.0 mmol/L, two-thirds ofcases had chronic
renal impairment and 10/18 cases were
precipitated by potassium-sparing diuretics. The
generally favourable prognosis of the condition
is emphasised by 15/18 patients making a good
recovery within hours to days, although the
potentially serious consequences are also
highlighted by the two deaths due to cardiac
arrest.10 Our patient had a major colorectal
operation 18 days before becoming paralysed.
An ACE inhibitor in combination with increased
ileostomy output leading to dehydration caused
progressive renal impairment, leading to
hyperkalaemia and secondary paralysis.
Progressive weakness and physical inability to
drink exacerbated the dehydration.
The prognosis for secondary hyperkalaemic
paralysis is good if recognised and treated.
Clinicians should be aware of this possible
complication in post-operative patients with
electrolyte disturbance secondary to increased
stoma effluent.
C The Ulster Medical Society, 2003.
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